Hannah Joseph Hospital Limited · BSE:HANNAH
Hannah Joseph Hospital — Investor Presentation (June 2026)
18 slides from Hannah Joseph Hospital's investor presentation, Jun 16, 2026
Slide 1: BSE filing cover letter: Investor Presentation under Regulation 30
NA your faith shall heal Hannah Joseph Hospital ( Institute of Neurosciences, Cardiac Sciences, Orthopaedics & Traumatology) HJHL/BSE/2026-27/17 16.06.2026 To The Listing Department BSE Limited P.J. Towers Dalal Street, Mumbai — 400001 Scrip Code: 544687 [Symbol: HANNAH]| ISIN: INEOJVHO01012 Dear Si
Slide 2: Investor Presentation
Hannah Joseph Hospital INVESTOR PRESENTATION Transforming Healthcare Through Clinical Excellence, Advanced Technology & Compassionate Care Building a Future of Accessible, High-Quality Healthcare Healing Lives. Building Trust.
Slide 3: Hannah Joseph Hospital
Hannah Joseph Hospital A Multi-Specialty Tertiary Care Hospital Focus: Neurosciences and Trauma Care 30+ World Class Amenities 133 bed multi-specialist hospital Revenue: INR 92.05 Crs (FY 26) 70+ Doctors
Slide 4: Company Overview
Company Overview Hannah Joseph Hospital is a trusted multi-specialty healthcare institution focused on delivering advanced, patient- centric medical care. With modern technology and a highly experienced team, the hospital is known for accurate diagnosis, effective treatment, and compassionate care,
Slide 5: Leadership Behind Hannah Joseph Hospital
Leadership Behind Hannah Joseph Hospital Our vision is to be an international center of excellence in Neurosciences, Accident and Trauma care Dr. Moses Joseph Arunkumar- Visionary Behind Hannah Joseph Promoter, Chairman & Managing Director 25+ years in Neurosurgery Ex-Apollo & CMC Vellore Former Pre
Slide 6: The Opportunity
THE OPPORTUNITY Radiation Oncology Centre Expansion Opportunity Brain & Spine Tumor Integrated Cancer Care Revenue Expansion Dedicated Oncology Leadership Campus Build on Hannah Joseph Surgery, Radiation Additional IPD and OPD Adjacent land already Hospital's recognized Therapy & revenue streams acq
Slide 7: Technology Edge
TECHNOLOGY EDGE BrainLab Navigation & AI-Powered Surgical Precision BrainLab Navigation DTI Fiber Tracking System 3.0 (AI) Real-time 3D image-guided surgical AI-powered visualization of critical neural navigation pathways Precise localization of brain and spinal tumors Supports preservation of funct
Slide 8: Oncology Services Portfolio
Oncology Services Portfolio Early Detection & Screening Advanced Diagnostics Palliative & Supportive Preventive cancer screening MRI & CT Imaging Care 01 programs 02 Neuro-radiology 03 Pain management Community awareness Pathology & Molecular Nutritional counseling initiatives Diagnostics Psychologi
Slide 9: Strategic Milestones
Strategic Milestones Demonstrating sustained growth through quality accreditations, advanced technology adoption, and industry recognition Won Time Business Launched DrNB Ranked #2 Best Award for Excellence in Neurosurgery Program Neurosurgery Hospital Neurosurgery & Trauma (6-year course) (All Indi
Slide 10: Financial Performance
y\/\ Your Faith shall Heal HANNAH JOSEPH HOSPITAL LIMITED FINANCIAL
Slide 11: Financial Overview
Financial Overview Revenue Revenue Mix (FY26) (FY26) HOSPITAL PHARMACY DIETARY ₹ 92.05 Cr ₹ 65.72 Cr ₹ 25.79 Cr ₹ 0.54 Cr 71.4% 28% 0.6% Insurance tie-ups Shareholding Pattern Public 34 Companies 19.11% DIIs 9.05% FIIs .56% Current capacity Promoters 71.28% 133 beds
Slide 12: Financial & Operational Highlights
Financial & Operational Highlights All figures in ₹ Crs. Particulars 31st March 2026 31st March 2025 31st March 2024 31st March 2023 Revene from operation 92.05 77.53 63.41 54.62 Revenue Growth Rate 18.73% 22.27% 16.09% EBITDA 24.96 20.52 17.98 16.38 EBITDA margin 27.12% 26.47% 28.35% 29.99% PAT 11.
Slide 13: Improvement in our Business performance over the past few years
Improvement in our Business performance over the past few years Revenues EBITDA 24.96 PAT (INR Crs) (INR Crs) 20.52 (INR Crs) 11.18 17.98 16.38 92.05 7.21 77.53 63.41 4.07 54.62 1.01 FY 23 FY 24 FY 25 FY 26 FY 23 FY 24 FY 25 FY 26 FY 23 FY 24 FY 25 FY 26 REVENUE CAGR EBITDA CAGR 19% 15.07%
Slide 14: Financial & Operational Highlights
Financial & Operational Highlights KPI FY23 FY24 FY25 FY26 Revenue from hospital 3,686 4,353 5,223 6,572 (₹ Lakhs) Average Bed Occupancy 46 49 57 57 Capacity Utilization (%) 34.63% 37.11% 42.49% 43.00% Average Length of Stay 12 13 15 14 ARPOB (₹ Lakhs) per 80 89 92 139 year Revenue/Bed/Day 22,000 24
Slide 15: Financial & Operational Highlights: ARPOB and Occupancy
Financial & Operational Highlights ARPOB Trend (Average Revenue per Occupied Bed) Average Bed Occupancy 57 Beds (₹ in Lakhs) 24.10% R Growth CAG 139 12.9 0% FY23: 46 Beds → FY26: 57 Beds 92 89 80 Revenue per Bed / Per Day ₹38,000 72.72% Growth FY23: ₹0.22 Lakh → FY26: ₹0.38 Lakh Capacity Utilization
Slide 16: Financial & Operational Highlights: Surgical Growth
Financial & Operational Highlights SURGICAL GROWTH - BAR CHART 400 402 Neurosurgery 344 347 300 303 402 236 Cases 200 199 16.12% 100 78 59 Orthopaedics &Trauma 0 Growth 236 2022-23 2023-24 2024-25 2025-26 SURGICAL GROWTH Cases 400 402 19.20% 344 347 303 300 236 199 Overall Surgical Growth 200 638 10
Slide 17: Achievements
ACHIEVEMENTS TIMES BUSINESS AWARD’26 FORTUNE INDIA -TRUSTED INDIA TODAY (MADURAI & TRICHY) BRANDS’25 EMINENT DOCTORS SOUTH’26 “EXCELLENCE IN NEUROSURGERY & TRAUMA CARE” “DR. M.J. ARUNKUMAR FEATURED” INDIA TODAY EMINENT DOCTORS SOUTH’26 INDIA TODAY OUTLOOK MAGAZINE’25 INDIA TODAY EMINENT DOCTORS SOUT
Slide 18: Thank You
KYRO Capital . Discipline . Trust Relations THANK YOU KYRO RELATIONS Investor Relations and Public Relations Partner +91 7777839077 irpr@kyrocapital.in Indore & Mumbai Disclaimer Kyro Relations operates as a separate division within Kyro Capital Private Limited. While both fall under the same legal
Hannah Joseph Hospital — Investor Presentation (June 2026) on 6ix